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a  b  s  t  r  a  c  t
Objectives. Earlier studies demonstrated that dental resin monomers lower cellular viability
and provoke oxidative stress. Reactive oxygen species (ROS) formation has a key role in
triethylene glycol dimethacrylate (TEGDMA) induced adverse reactions. In the present study
the effects of TEGDMA on mitochondrial functions were investigated to identify a direct
molecular target for cytotoxicity.
Methods. Mitochondria were isolated from guinea pig brain. The most important bioenergetic
parameters, oxygen consumption, membrane potential (m), and ATP production were
assessed. Mitochondrial H2O2 production and elimination and the NAD(P)H level reported
on  redox balance.
Results. Mitochondria were supported with respiratory substrates to be oxidized by either
Complex I (CI) or Complex II (CII). m was depolarized, respiration and ATP production




parameters remained essentially unaffected when CII substrate plus TEGDMA were applied.
H2O2 production by mitochondria was significantly stimulated by TEGDMA in the pres-
ence of CI substrates. In the presence of TEGDMA mitochondrial elimination of exogenous
H2O2 was impaired. When CII substrate supported the mitochondria in the absence of ADP
the  H2O2 generation was decreased. NADH autofluorescence results also demonstrated theinhibitory effect of TEGDMA on CI activity.
Abbreviations: AK, adenylate kinase; ANT, adenine-nucleotide translocator; -KG, alpha-ketoglutarate; -KGDH, alpha-ketoglutarate
dehydrogenase; AP5, P1,P5-di(adenosine-5′) pentaphosphate; BSA, bovine serum albumin; CAT, carboxyatractylate; m, mitochondrial
membrane potential; DMSO, dimethyl-sulfoxide; DTNB, 5,5′-dithiobis(2-nitrobenzoic acid); FCCP, carbonylcyanide-p-trifluoromethoxy-
phenylhydrazone; GM, glutamate plus malate; OXPHOS, oxidative phosphorylation; SLP, substrate-level phosphorylation; Succ, succinate.
∗ Corresponding author at: Department of Medical Biochemistry, Semmelweis University, Tűzoltó st. 37-47, H-1094 Budapest, Hungary.
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Significance. TEGDMA inhibits CI in the respiratory chain, which explains effects induced by
TEGDMA on redox homeostasis, apoptotic and necrotic cell deaths described in previous
studies. Identification of the molecular target of TEGDMA may influence the development
of  relevant biomaterials and may induce new therapeutic strategies to control the adverse
effects of resin monomers.

















































ental composite resins are commonly used to restore
tructural tooth damages. The development of resin-based
omposites (RBCs) has resulted in esthetically pleasing and
ong lasting dental restorations [1]. Recently, biocompatibil-
ty of the filling materials has become a clinically relevant
ssue [2]. Most RBCs contain strongly viscous major monomers
nd co-monomers of lower viscosity such as triethylene glycol
imethacrylate (TEGDMA) [3–5]. Incomplete RBC polymeriza-
ion may lead to an undesired leaching of the monomers into
he oral tissues [6,7]. TEGDMA is of amphiphilic character and
he most common co-monomer released from polymerized
omposites [5,8–10]. Shortly after the polymerization pro-
ess was considered to be completed, both 2-hydroxyethyl
ethacrylate (HEMA) and TEGDMA were detectable in the
aliva in millimolar concentrations [5,6,11,12]. After months
nd years, mechanical deterioration and hydrolytic disinte-
ration by unspecific salivary esterases may induce further
elease of the resin monomers, which are able to cross the
entin, enter the pulp, and reach concentrations that may
ndeed affect cellular functions [8,13]; the concentration of
EGDMA in the pulp was shown to reach levels of up to
 mM [11,14,15]. The systemic blood concentrations of the
onomers are orders of magnitude lower [6], therefore the
robability of the development of TEGDMA-induced adverse
ystemic effects is negligible [9]. TEGDMA and HEMA were
eported to affect various cellular functions and the viability
f the cells in the oral cavity [12,16–18]. It was reported earlier
hat TEGDMA could initiate cell stress responses, induce reac-
ive oxygen species (ROS) generation, and cause glutathione
epletion in a wide variety of eukaryotic cells in vitro [12,19,20].
he genotoxic [21] and mutagenic effects of TEGDMA are
ikely consequences of ROS-triggered DNA damages; the toxic
ffects could apparently be eliminated applying ROS scav-
ngers [18,22–25]. It was demonstrated that TEGDMA could
nduce, depending on the concentration, apoptotic [26,27] or
ecrotic cell death [27–30].
These results in the literature raise the possibility of a
ommon mechanism and perhaps molecular target which
ould be responsible for the observed cellular changes, how-
ver, the underlying mechanism behind these phenomena
emains poorly understood. Recently the involvement of
ADPH oxidase 4 (NOX 4) in TEGDMA-induced apoptosis and
OS generation was described [31]. Earlier a collapsed mito-
hondrial membrane potential and increased ROS formation
ere detected in gingival fibroblasts after a treatment with
EGDMA [32]. Mitochondrial dysfunction certainly influences
ell viability as the decreased ATP level can lead to necroticcell death. Mitochondrial impairment can increase the level
of ROS, provoke DNA damages, and consequently induce apo-
ptosis [33]. Therefore, it appeared to be plausible to seek after
mitochondrial targets in order to understand the mechanism
of TEGDMA-induced toxicity. Taking into account that mito-
chondrial impairment can either be primary or secondary,
and that the distinction is not always clear in a cellular sys-
tem, isolated mitochondria were chosen as the objects of this
study. According to our hypothesis, most of the toxic effects of
TEGDMA could potentially be explained by the development of
bioenergetic insufficiency and increased ROS generation. The
hypothesis that mitochondrial dysfunctions could be respon-
sible for the onset of either necrotic [34,35] or apoptotic cell
death [36] does not demand any sophisticated verification.
Low doses of Complex I (CI) inhibitors generally induce apo-
ptosis, while higher doses of the same compound may evoke
necrotic cell death [37].
The role of mitochondria in cellular generation of ROS is
also well known [38]. Various mechanisms and molecular enti-
ties can be responsible for the enhanced ROS generation of
mitochondria [39,40].
In the present study, low millimolar concentrations of
TEGDMA were used to challenge isolated brain mitochondria
and the most important bioenergetic functions were evalu-
ated in parallel with the measurement of mitochondrial H2O2
homeostasis. We propose that inhibition of the mitochondrial
respiratory CI may be responsible for most of the cytotoxic
effects of TEGDMA.
2.  Materials  and  methods
2.1.  Preparation  of  brain  mitochondria
Animal experiments were performed in accordance with
the relevant guidelines of the National Institute of Health
(USA) and the Semmelweis University. Mitochondria were
isolated from guinea pig brain cortex using a Percoll gradi-
ent as detailed elsewhere [41]. Unless otherwise indicated,
0.1 mg/mL  mitochondrial protein concentration was applied
for all the experiments.
2.2.  Incubation  medium
Measurements were carried out at 37 ◦C in an assay medium
containing the following components: 125 mM KCl, 20 mM
HEPES, 2 mM K2HPO4, 1 mM MgCl2, and 0.025 (w/v) % bovine
serum albumin (BSA; free of fatty acids). Mitochondria were
energized by either alpha-ketoglutarate (-KG), or glutamate
 s 3 4e168  d e n t a l m a t e r i a l
plus malate (GM), or succinate (Succ), all in 5 mM concentra-
tion.
2.3.  Measurement  of  mitochondrial  oxygen
consumption
Mitochondrial respiration was monitored using the high-
resolution respirometry system Oxygraph-2k [42] (Oroboros
Instruments, Innsbruck, Austria). Oxygen sensors were cali-
brated at air-saturation and in oxygen-depleted media.
2.4.  Measurement  of  mitochondrial  membrane
potential  ( m)
Mitochondrial  m was detected using safranine O (2 M).
This lipophilic cationic dye gets distributed among mitochon-
dria and the surrounding medium; the value of the partition
coefficient is the function of the actual mitochondrial  m.
Measurements were performed using a Hitachi F-4500 spec-
trophotometer (Hitachi High Technologies, Maidenhead, UK)
at 495 and 585 nm excitation and emission wavelengths,
respectively, as described previously [43].
2.5.  Parallel  measurements  for  H2O2 and  NAD(P)H
H2O2 formation by isolated mitochondria was detected using
the Amplex Ultra Red fluorescence assay (for review, see Ref.
[44]). In this assay, Amplex Ultra Red (3 M) is converted
to the highly fluorescent compound resorufin by H2O2 and
horseradish peroxidase (5 U/2 mL). Fluorescence was detected
using a PTI Deltascan fluorescence spectrophotometer (Pho-
ton Technology International, Lawrenceville, NJ, USA); for
excitation and emission, the 550 and 585 nm wavelengths
were applied, respectively. Each measurement was calibrated
by 100 pmol H2O2 at the end of the experiment. In a paral-
lel experiment, using the double-excitation/double-emission
mode of the spectrofluorimeter, NAD(P)H fluorescence was
also measured at 340 and 466 nm excitation and emission
wavelengths, respectively.
2.6.  Measurement  of  mitochondrial  H2O2 elimination
Mitochondrial elimination of H2O2 was measured as previ-
ously described [45]. Briefly: glutamate plus malate supported
mitochondria (0.1 mg/mL) were preincubated in either the
presence or absence of TEGDMA (5 mM)  or DMSO for 5 min.
At 5 min  H2O2 (10 M)  was given, then 50 L samples were
taken at 30 s intervals for 2 min, and the residual H2O2 was
determined by Amplex Ultra Red fluorimetry, as described in
the previous Section 2.5. Measurements were calibrated with
known amounts of H2O2.
2.7.  Measurement  of  reduced  glutathione  consumption
The measurement of reduced glutathione (GSH) is based
on the reaction of the thiol SH group with 5,5′-dithiobis(2-
nitrobenzoic acid) (DTNB). Freshly diluted GSH (2 mM)  was
incubated in the reaction medium at 37 ◦C for various time
intervals. Aliquots were taken and the generated TNB was
measured via spectrofotometry at 412 nm [46]. ( 2 0 1 8 ) e166–e181
2.8.  Measurement  of  ATP  production
ATP production by isolated mitochondria was detected using
a coupled enzyme assay that applies hexokinase and glucose-
6-phosphate dehydrogenase, as described previously [47]. The
assay medium was supplemented with 3 mM NADP+, 1.5 U
hexokinase, 0.5 U glucose-6-P dehydrogenase, 5 mM glucose,
and 200 M 2-amino-phosphono-phentanoate (an adenylate
kinase inhibitor). Mitochondria (0.05 mg/mL), ADP (2 mM),
glutamate plus malate (5–5 mM)  or succinate (5 mM), and
TEGDMA (5 mM)  were added as indicated in the corresponding
figures. ADP was converted to ATP, which left the mitochon-
drion via the adenine nucleotide translocase (ANT). In the
medium, ATP phosphorylated glucose via hexokinase and the
produced glucose-6-phosphate got further converted to 6-
phosphogluconate via glucose-6-phosphate dehydrogenase;
with the concomitant reduction of NADP+ to NADPH. Light
absorbance of NADPH was recorded at 37 ◦C and 340 nm
(ε = 6220 M−1 cm−1) using a JASCO spectrophotometer (ABL&E-
JASCO V-650, Tokyo, Japan).
2.9.  Detection  of  mitochondrial  respiratory  Complex  I
activity
For the Complex I assay the method described by Ragan and
Hatefi [48] was used. The assay measures the rate of the
conversion of NADH to NAD+ while the electron acceptor is
Coenzyme Q1 (CoQ1). Mitochondria were incubated in the
standard medium and subsequently frozen and thawed three
times. Thereafter, 200 g was transferred into the following
medium: 100 mM KH2PO4, 40 M Coenzyme Q1, 1 mM KCN, pH
7.4. 50 M NADH initiated the reaction, which was repeated in
the presence of either 5 mM TEDGMA or 1 M rotenone. The
initial rate of the change in absorbance at 340 nm was detected
at 37 ◦C using a JASCO spectrophotometer.
2.10.  Chemicals
TEGDMA was obtained from VOCO GmbH (Cuxhaven,
Germany) and dissolved in dimethyl sulfoxide (DMSO); the 1 M
stock solution was stored at −20 ◦C. The purity of triethylene
glycol dimethacrylate was 97%; the remaining 3% was triethy-
lene glycol monomethacrylate. The content of UV inhibitor is
150 ppm HQME (hydroquinone monomethyl ether) (0,015%),
which is usual for a methacrylate monomer.
Standard laboratory chemicals were purchased from Sigma
(St. Louis, MO, USA). The Amplex Ultra Red reagent was from
Molecular Probes (Eugene, OR, USA).
2.11.  Statistics
Pairwise comparisons were evaluated by Student’s t-test. Sta-
tistical differences for multiple comparisons were evaluated
using the one-way ANOVA method, or for data not following
normal distribution ANOVA on ranks Kruskar Wallis test was
applied. Values of p < 0.05 were considered to be statistically
significant.






















































d e n t a l m a t e r i a l s 3
.  Results
.1.  The  effect  of  TEGDMA  on  mitochondrial
espiration
itochondria were energized with by either alpha-
etoglutarate (-KG), or glutamate plus malate (GM) or
uccinate (Succ) as respiratory substrate. NADH is formed
hen either -KG or GM gets oxidized inside the mitochon-
rion. Since the produced NADH is oxidized by CI, -KG
nd GM are both considered to be Complex I substrates;
hereas oxidation of succinate is predominantly associated
ith Complex II. Oxidative phosphorylation (OXPHOS) was
nitiated by ADP (2 mM).  Afterwards, mitochondria were
hallenged with TEGDMA. Experiments were terminated
ith carboxyatractylate (CAT) (2 M)  which inhibits ADP-ATP
xchange [49].
.1.1.  Oxidation  of  Complex  I  substrates
n the presence of ADP oxygen consumption was increased
rom 12 ± 1 to 98 ± 2 nmol/min/mg protein in -KG-supported
itochondria (Fig. 1A for original traces and Fig. 1B). The
igh respiratory control ratio (RCR: oxidation rate in the
resence of ADP vs oxidation rate in the absence of ADP)
ndicated the high quality of mitochondrial preparations
sed in this study (RCR > 7). A subsequent administration of
EGDMA (5 mM)  resulted in 69% decrease in oxygen consump-
ion (from 98 ± 2 to 30 ± 2 nmol/min/mg protein) (Fig. 1A,B).
hallenging mitochondria with an ANT inhibitor decreased
he -KG-supported respiration both in the absence and
resence of TEGDMA (Fig. 1A,B). In GM-energised mito-
hondria, respiration was stimulated by ADP from 25 ± 2 to
00 ± 9 nmol/min/mg protein. Similarly to the effect observed
ith -KG, addition of TEGDMA (5 mM)  decreased the rate
f the ADP-stimulated respiration by 88% (from 200 ± 9 to
4 ± 3 nmol/min/mg protein). Significant effect of TEGDMA
n ADP-stimulated O2 consumption was detected from 2 mM
oncentration (Fig. 1C). CAT lowered the rate of oxygen
onsumption both in TEGDMA-treated and non-treated mito-
hondria.
.1.2.  Oxidation  supported  by  a  Complex  II  substrate
nlike with the NADH-linked substrates, in succinate-
upported mitochondria TEGDMA given after ADP did not
nfluence significantly the rate of oxygen consumption (from
66 ± 10 nmol/min/mg protein to 159 ± 5 nmol/min/mg pro-
ein) (Fig. 1D). These results unequivocally imply that TEGDMA
oes not inhibit Complex II function.
.2.  Effect  of  TEGDMA  on  the  mitochondrial
embrane  potential  ( m)
he  m is an important parameter of mitochondrial bioen-
rgetic competence, whose building up is a prerequisite for
fficient OXPHOS-dependent ATP synthesis.  m was mea-
ured in isolated mitochondria supported by either -KG
r GM or Succ. The experimental protocol was identical
o that of the oxygen consumption measurement (Sec-
ion 3.1). In the presence of respiratory substrates, the 0 1 8 ) e166–e181 e169
inner membrane became hyperpolarized (Fig. 2), indicated
by a decrease of safranin fluorescence.  m was higher in
GM-supported mitochondria than in mitochondria respir-
ing on -KG, reflecting the higher rate of oxidation of GM
(Figs. 2A,B and 1B,C). Subsequent addition of ADP caused
depolarization with both substrates. Both in -KG and
in GM supported mitochondria, TEGDMA induced further
depolarization (Fig. 2A,B trace b). Addition of CAT to TEGDMA-
treated mitochondria resulted in a complete depolarization,
as opposed to control mitochondria where CAT induced
membrane hyperpolarization. The total depolarization of
mitochondria was achieved using uncoupler carbonylcyanide-
p-trifluoromethoxy-phenylhydrazone (FCCP) (250 nM). Con-
trary to that observed with CI substrates in succinate
supported mitochondria TEGDMA did not depolarize mito-
chondria in the presence of ADP and subsequent addi-
tion of CAT resulted in an elevation of  m both in
TEGDMA-treated mitochondria and in control condition
(Fig. 2C).  Consequently m measurements also support the
notion that Complex I activity is selectively inhibited by
TEGDMA.
3.3.  The  effect  of  TEGDMA  on  H2O2 generation  and
elimination
The prominent role of mitochondria in modulation of redox
homeostasis is widely accepted [40,50]. Mitochondria partici-
pate not only in ROS generation, but also in ROS detoxication
(for review see Ref. [44]). In the following experiments,
mitochondrial H2O2 production and elimination were both
measured in the presence of CI substrates and H2O2 produc-
tion was also measured with non-CI substrates like Succ and
alpha-glycerophosphate (-GP).
3.3.1.  H2O2 formation  in  mitochondria  supported  by
NADH-linked  substrates
GM and -KG both initiated H2O2 production in mito-
chondria, as demonstrated in Fig. 3A,B. Addition of
TEGDMA elevated ROS production by 17% (from 358 ± 16
to 420 ± 25 pmol/min/mg protein) (Fig. 3B). Addition of ADP
resulted in a reduction in the rate of H2O2 production
[41,51] in mitochondria energized by either -KG or GM,
due to depolarization of the inner mitochondrial mem-
brane. TEGDMA augmented the rate of H2O2 production
by 18% (from 81 ± 2 to 99 ± 4 pmol/min/mg protein) in -
KG-supported mitochondria (Fig. 3A), and by 74% (from
84 ± 6 to 146 ± 8 pmol/min/mg protein) in GM-supported
mitochondria (Fig. 3B and B inset). Significant stimulation
of H2O2 production has already been observed at 2 mM
TEGDMA (Fig. 3B). The addition of CAT caused remarkable
stimulation of H2O2 formation both in the presence and
absence of TEGDMA. It is known that the horseradish per-
oxidase (HRP)-Amplex Ultra Red system not only detects
H2O2 formation, but it also eliminates H2O2 [44] mitigating
the H2O2-mediated oxidative stress. In order to assess the
effect of TEGMA without this interference, mitochondria
were pretreated with TEGDMA for 10 min  in the presence
of glutamate plus malate and the absence of Amplex plus
HRP.
e170  d e n t a l m a t e r i a l s 3 4 ( 2 0 1 8 ) e166–e181
Fig. 1 – Effects of TEGDMA on the O2 consumption rate of the isolated brain mitochondria in the presence of various
respiratory substrates: -ketoglutarate (-KG; A,B), glutamate plus malate (GM; C), or succinate (Succ; D). Mitochondria were
incubated in the ‘standard medium’ described under Section 2. ADP, TEGDMA (gray curve), DMSO (black curve), and
carboxyatractylate (CAT) were  given as indicated on the original traces (1A). The effects of TEGDMA (white bars) (with various
concentrations in GM-supported mitochondria as well 1C)  are compared to controls (gray bars, no TEGDMA only DMSO was
added). Oxygen consumption, written on the bars, is expressed in nmol/min/mg protein (mean ± SEM). Significant
differences are indicated *p < 0.05.
d e n t a l m a t e r i a l s 3 4 ( 2 0 1 8 ) e166–e181 e171
Fig. 2 – The effect of TEGDMA on  m in -ketoglutarate (A), glutamate plus malate (B) and succinate (C) respiring brain
mitochondria. Mitochondria (0.1 mg/mL) were  incubated in standard medium as described in Section 2. TEGDMA (5 mM),
-ketoglutarate (-KG; 5 mM),  glutamate plus malate (GM; 5–5 mM),  succinate (Succ; 5 mM),  ADP (2 mM),  carboxyatractylate
(CAT; 2 M)  and FCCP (250 nM)  were  added as indicated. The effect of TEGDMA (dark grey; trace b) is compared with controls









without TEGDMA black; trace a). Traces represent the averag
.3.2.  Effect  of  pretreatment  with  TEGDMA  on  ROS
roduction
fter the 10 min  preincubation, H2O2 production was mea-
ured by Amplex plus HRP. In the presence of TEGDMA
5 mM)  H2O2 production was stimulated by 56% (from 369 ± 8
o 576 ± 12 pmol/min/mg protein) (Fig. 4A). Addition of ADP
ecreased the rate of H2O2 formation, but in the presence of
EGDMA 95% stimulation was detected.EM of four independent experiments.
3.3.3.  H2O2 elimination  in  mitochondria  supported  by
NADH-linked  substrates
Mitochondria were challenged with exogenous H2O2 in the
presence or absence of TEGDMA (5 mM)  and the disappearance
of H2O2 was tested as described in Section 2. In the presence
of TEGDMA a significant decrease in H2O2 elimination was
observed (Fig. 4B).
e172  d e n t a l m a t e r i a l s 3 4 ( 2 0 1 8 ) e166–e181
Fig. 3 – Effects of TEGDMA on H2O2 production in the isolated brain mitochondria supported by -ketoglutarate (-KG; A),
glutamate plus malate (GM; B), succinate (Succ; C), or -glycerophosphate (20 mM)  (-GP; D). In the inset of B, original traces
and numbers that represent the rates of H2O2 production (in pmol/min/mg protein) are displayed. Carboxyatractylate (CAT)
was added as indicated to the mitochondria incubated with GM,  ADP, TEGDMA (gray curve), or DMSO (black curve)  (Inset B).
For A–D, the rates of H2O2 production were  also demonstrated on a bar chart (mean ± SEM; white bars: TEGDMA was present,
grey bars: no TEGDMA was present). Statistical analysis was applied as above (see Fig. 1).
d e n t a l m a t e r i a l s 3 4 ( 2 0 1 8 ) e166–e181 e173
Fig. 4 – Effects of preincubation of mitochondria with TEGDMA on H2O2 production (A), and H2O2 elimination (B).
Mitochondria were  preincubated for 10 min  with Complex I substrate glutamate plus malate (5–5 mM)  in the incubation
medium in the absence (grey bars) or presence of TEGDMA (white bars). After this 10 min, horseradish peroxidase and
Amplex Ultra were  added (as described in Section 2) and H2O2 production was measured. Data are expressed as
mean ± SEM (n ≥ 7) (A). Removal of exogenously added H2O2 by glutamate plus malate supported mitochondria in the
presence or absence of TEGDMA (5 mM).  Mitochondria (0.1 mg/ml) were  incubated for 10 min, then challenged with H2O2
(10 M).  The residual H2O2 was measured from aliquots taken after different time intervals, as described in Section 2. Data


























re expressed as mean ± SEM (n = 9) (B). Significant results (p
.3.4.  The  interaction  of  TEGDMA  with  GSH
imilarly to the experiments described elsewhere [52], the
eaction of GSH with TEGDMA (5 mM)  was investigated in a
itochondrion-free reaction medium. At 15 min  of incubation
ime a 3.7% decrease in GSH concentration was detected in the
resence of TEGDMA (5 mM)  (Fig. 5).
.3.5.  H2O2 formation  in  the  courses  of  oxidation  of
on-Complex  I  substrates
.3.5.1.  H2O2 generation  in  mitochondria  supported  by  suc-
inate. TEGDMA or DMSO were applied to mitochondria
nergized with succinate. TEGDMA (5 mM)  decreased the
ate of H2O2 production by 42% (from 3454 ± 245 to
988 ± 163 pmol/min/mg protein). Significant decrease of
2O2 formation has been observed already at 0.5 mM of
EGDMA. Addition of ADP further decreased H2O2 pro-
uction to 423 ± 78 pmol/min/mg protein in the presence
f TEGDMA (5 mM)  and to 301 ± 36 pmol/min/mg protein
n DMSO-treated mitochondria (Fig. 3C).  Inhibition of ANT
y CAT stimulated again the ROS production. H2O2 gen-
ration in TEGDMA-treated group (1241 ± 227 pmol/min/mg
rotein) was significantly lower than that of control group
6348 ± 400 pmol/min/mg protein) (Fig. 3C) owing to the CI
nhibition..3.5.2.  H2O2 formation  in  mitochondria  supported  by  ˛-GP.  In
rain mitochondria alpha-glycerophosphate dehydrogenase05) are indicated by asterisks (A and B).
(-GPDH) is highly active [53]. This enzyme (such as succinate
dehydrogenase) provides the respiratory chain with electrons
and can also generate RET. In -GP-energized mitochondria
TEGDMA mediated a 47% suppression of H2O2 production
(from 491 ± 30 to 259 ± 20 pmol/min/mg protein) (Fig. 3D).
Addition of ADP lowered the rate of H2O2 generation in both
groups. In the presence of ADP there was no observable differ-
ence between the two treatments (DMSO or TEGDMA). Under
control conditions CAT restored the rate of H2O2 production
to the level detected in the ADP-free state (from 117 ± 13
to 509 ± 29 pmol/min/mg protein). In TEGDMA-treated mito-
chondria there was also a CAT-mediated stimulation of H2O2
generation (from 111 ± 16 to 185 ± 14 pmol/min/mg protein),
but the effect was much smaller than the one measured in
solvent-treated mitochondria (Fig. 3D).
3.4.  Effects  of  TEGDMA  on  the  NAD(P)H  level
The application of both NADH-linked (-KG, GM) and FADH2-
linked substrates (Succ and -GP) elevated the mitochondrial
NAD(P)H level (Fig. 6). The elevation of the NAD(P)H level by
Succ and/or -GP can likely be ascribed to the RET mecha-
nism [54–56]. The ADP-induced stimulation of respiration was
accompanied by a decreased steady-state level of NAD(P)H.
In TEGDMA-treated mitochondria the NAD(P)H steady-state
level was higher both with either NADH or FADH2-linked sub-
strates (Fig. 6 traces b). In mitochondria respiring on -KG the
e174  d e n t a l m a t e r i a l s 3 4
Fig. 5 – Effect of incubation with TEGDMA on the GSH level
in mitochondrion-free medium. GSH (2 mM)  was incubated
with TEGDMA (5 mM)  in the standard incubation medium
and at the time intervals indicated aliquots were  taken and
the reduced glutathione concentration was determined by
5,5′-dithiobis(2-nitrobenzoic acid) (DTNB),
spectrophotometrically (ε412 = 13600 M−1 cm−1). Results are
expressed as percentage of original GSH concentration;
mean ± SEM (n ≥ 7). Significance (p < 0.05) is indicated by
asterisk.
the succinate-dependent respiration. In the present study, the
reduced rates of mitochondrial respiration observed in theTEGDMA-induced elevation of the NAD(P)H level was slow and
gradual (Fig. 6A), but in GM-supported mitochondria TEGDMA
induced a fast elevation of the NAD(P)H level (Fig. 6B). In the
presence of CAT there was no difference in the NAD(P)H steady
state between control and TEGDMA challenged mitochon-
dria (Fig. 6). However, in TEGDMA-treated succinate-energized
mitochondria ADP did not decrease the NADP(H) level at all,
contrary to TEGDMA-treated -GP-supported mitochondria
where a moderate decrease of the NAD(P)H level was observed
(Fig. 6C,D traces b).
3.5.  Effect  of  TEGDMA  on  ATP  synthesis
For a better characterization of the relevant mitochondrial
bioenergetics, in addition to oxygen consumption and  m
the rate of ATP production was also assessed (Fig. 7). After
administering ADP, in the absence of respiratory substrates,
a compromised rate of the adenylate kinase (AK) coupled
ATP synthesis (18 ± 2 nmol/min/mg protein) could still be
detected as 200 M AP5 was apparently not sufficient to fully
inhibit the activity of AK. OXPHOS was initiated with the
addition of respiratory substrates in the presence of ADP.
In GM-supported TEGDMA-treated mitochondria the rate of
ATP production was lowered by 86% (decreased from 824 ± 23
to 113 ± 13 nmol/min/mg protein) as compared with controls.
However, addition of TEGDMA (5 mM)  to succinate-energized ( 2 0 1 8 ) e166–e181
mitochondria resulted in a drop of 10.2% only in the rate of ATP
synthesis (from 561 ± 24 to 504 ± 25 nmol/min/mg protein).
3.6.  The  effect  of  TEGDMA  on  Complex  I  activity
In order to prove our hypothesis that TEGDMA was an inhibitor
of CI, the NADH-CoQ reductase activity was directly measured.
The CI activity was decreased by 70.6 ± 3.3 and 61.8 ± 3.2% in
the presence of 5 and 2 mM TEGDMA, respectively (data not
shown).
4.  Discussion
It has been shown that TEGDMA release due to incomplete
polymerization and biodegradation in oral environment can
impair various cellular functions, provoke oxidative stress
(for review see Ref. [18]), apoptotic and necrotic cell death
[28,30,57,58] and trigger genetic mutations [8,59]. Selected
resin monomers were demonstrated to deplete the pool of
glutathione (GSH), an intracellular antioxidant [12]. Inhibition
of cell proliferation, stimulation of apoptosis and impaired
differentiation of osteoclasts [60] can be all mediated by the
overproduction of ROS. The beneficial effects of antioxidants
e.g. N-acetylcysteine (NAC), Trolox (vitamin E), or ascorbic
acid (vitamin C) also suggest that the cytotoxic effects of
TEGDMA would be the consequences of increased ROS gen-
eration [20,57,61–65]. The cellular mechanism that lies behind
the increased rate of ROS production has not been elucidated
yet [18]. The involvement of the mitochondrion in TEGDMA
toxicity has already been proposed [32]. A recent study empha-
sized the importance of the TEGDMA-mediated activation of
NOX4 in the ROS generation and apoptosis [31]. Since most of
the ATP, required for various cellular functions, is produced
by mitochondria, this organelle plays a pivotal role in cellular
viability and death. The mitochondrion is also a primary site
for ROS production and elimination (for review, see Ref. [38]).
Therefore, we  investigated the responses of various mitochon-
drial functions to TEGDMA.
4.1.  Effects  of  TEGDMA  on  mitochondrial  respiration
Mitochondrial respiration is a sensitive indicator of mitochon-
drial function [66]. In mitochondria which were supported by
either -KG or GM TEGDMA (5 mM)  led to a decrease in oxygen
consumption (Fig. 1A–C), whereas in FADH2-linked, succinate-
supported mitochondria the rate of oxygen consumption was
not affected by this treatment (Fig. 1D). Our results are in
contrast with an earlier observation [67] where the respira-
tion of isolated succinate-rotenone-supported mitochondria
was inhibited by TEGDMA; this contradiction might be due
to different experimental setups. In the above paper HL-60
cells were preincubated with TEGDMA for 1 h, and mitochon-
dria were isolated and investigated thereafter. In the course
of the incubation period mitochondria might have undergone
such a structural damages that could potentially also impairpresence of CI substrates can potentially be explained by: (i) a
decreased ATPase activity [68–70], (ii) the inhibition of ANT
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Fig. 6 – Effects of TEGDMA on the steady-state level of NAD(P)H in the brain mitochondria supported by -ketoglutarate (A),
glutamate plus malate (B), succinate (C), or -glycerophosphate (D). Mitochondria (0.1 mg/mL) were incubated with various











epresentative original traces of experiments are displayed 
as present).
71], (iii) a reduced rate of transport for metabolites and/or
norganic phosphate [72], or (iv) the compromised activities
f CI and/or selected dehydrogenase enzymes [73,74]. How-
ver, the normal rate of respiration which was detected in the
resence of succinate excluded the reasons listed under i, ii,
nd partially iii. In order to elucidate the mechanism that lies
ehind the depression of respiration the effects of TEGDMA
n mitochondrial  m were assessed., trace b: TEGDMA was present; black, trace a: no TEGDMA
4.2.  Effects  of  TEGDMA  on  mitochondrial   m
Maintenance of the mitochondrial membrane potential is
crucial for normal mitochondrial physiology. The proton gra-
dient is used by mitochondria to facilitate transport processes
for ions [75], metabolites [76] and proteins [77] across the
mitochondrial inner membrane. Previously, m was mea-
sured in gingival fibroblasts and mitochondrial depolarization
e176  d e n t a l m a t e r i a l s 3 4
Fig. 7 – Effects of TEGDMA on the rate of ATP synthesis in
brain mitochondria respiring on either glutamate plus
malate or succinate. TEGDMA (white bars) or DMSO (grey
bars) were  applied besides ADP throughout all the
experiments. The rate of ATP synthesis, written on the
bars, is expressed in nmol/min/mg protein (mean ± SEM)
interfere with the antioxidant system. In the excellent papern > 11. Significant differences are indicated by *p < 0.05.
was detected [32]. In cellular systems, however, mitochon-
dria are energized simultaneously with various respiratory
substrates and hence it is difficult to determine the true
target of a compound. In the present study, m mea-
surements also confirmed that TEGDMA inhibits the CI. In
mitochondria supported with NADH-linked substrates, addi-
tion of TEGDMA decreased m (Fig. 2A,B). Contrary to
that, in succinate-energized mitochondria m was unaf-
fected by TEGDMA (Fig. 2C). These findings again prove that
TEGDMA does not inhibit the ANT or the ATP-ase; when
using selective inhibitors of these molecules m would
have been hyperpolarized, independently of the respira-
tory substrates applied [78]. The results are consistent with
the proposed inhibitory effect of TEGDMA on the CI func-
tion.
4.3.  Effects  of  TEGDMA  on  ROS  homeostasis
As we  discussed earlier, there is a general agreement
that exposition of cells to TEGDMA provokes oxidative
stress. However, the sources and mechanisms of the redox
imbalance have not been elucidated, yet. Very recently it
was suggested that the activation of NADPH oxidase 4
has a key role in the TEGDMA-associated ROS generation
[31].
Our hypothesis that mitochondrial targets are also involved
in the cellular toxicity of TEGDMA would be substantiated if
administration of TEGDMA could stimulate the mitochondrial
ROS production. ( 2 0 1 8 ) e166–e181
4.3.1.  H2O2 formation  with  respiratory  substrates  linked
to Complex  I
The addition of respiratory substrates to mitochondria initi-
ated mitochondrial H2O2 generation (Fig. 3). Both -KG  and
GM stimulated the H2O2 production, but to different extent
(Fig. 3A,B). The higher rate of H2O2 production with GM can be
ascribed to the higher rate of GM-induced respiration (Fig. 1C)
and to the consequently higher  m (Fig. 2B) [51]. There is a
direct correlation between the membrane potential and H2O2
production (Figs. 2A,B and 3A,B) and Starkov et al. [51]. Addi-
tion of ADP differently inhibited H2O2 formation on -KG and
GM respiring mitochondria (Fig. 3A,B). The higher was the
membrane potential before the ADP addition, the greater was
the decrease of H2O2 production (Fig. 3A,B). Taking into consid-
eration that the -KGDH is the rate-limiting (slowest) enzyme
of the citric acid cycle in brain mitochondria, it is obvious that
the respiration rate, as well as the rate of H2O2 production, is
slower with -KG than with GM.  When it was given after ADP,
TEGDMA significantly augmented the rate of H2O2 production
and this was valid under both experimental conditions (with
-KG: 18% increase, with GM: 74% increase, relative to con-
trols; see Fig. 3A,B). Elevated rates of H2O2 production were
observed in the presence of CI inhibitors; CI possesses sev-
eral sites that are capable of producing ROS (for review see
Ref. [79]). In the electron transport chain, those electron carrier
complexes that are upstream to the binding site of a respira-
tory chain inhibitor are in highly reduced states [40]. Reduction
of a ROS-forming site increases the likelihood for an electron
leakage. Inhibition of CI in CI substrate (glutamate plus malate)
supported mitochondria stimulated H2O2 formation in either
the presence or absence of ADP. Enhanced H2O2 production
therefore can deplete endogenous antioxidants such as glu-
tathione and inhibit glutathione-related antioxidant systems
[80].
Comparing the results depicted in Figs. 3B and 4A, it is
apparent that as a consequence of the Amplex plus HRP-
free preincubation the stimulatory effect of TEGDMA  on H2O2
production was further enhanced in either the presence or
absence of ADP. We interpret these results that continuous
monitoring of mitochondrial H2O2 production with Amplex
plus HRP not only detects, but also detoxifies the generated
H2O2 [44] mitigating the oxidative damage.
Considering that mitochondria play roles in both ROS for-
mation and ROS elimination, the effect of TEGDMA on the
elimination of exogenous H2O2 was also investigated. Our
results indicate (Fig. 4B) that in the presence of TEGDMA the
elimination was indeed slower, therefore these results fur-
ther confirm the hypothesis drawn from the preincubation
experiment that TEGDMA can impair the antioxidant system.
This phenomenon can also be attributed to the inhibition
of Complex I, which results in a decrease in the mitochon-
drial membrane potential.  m is a driving force for the
energy-dependent transhydrogenase enzyme that can trans-
fer electrons from NADH to NADP+ [81], thus can maintain the
NADPH level, which is necessary for the regeneration of GSH.
However, it is still obscure whether TEGDMA can directlyof Lefeuvre et al. [52] the direct effect of TEGDMA on GSH
has been investigated and it was found that incubation of
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EGDMA (3 mM)  with GSH decreased the GSH concentration
n the absence of cells. After 1 and 3 h of incubation signifi-
ant decrease of [GSH] was detected. We  reinvestigated this
uestion and using 5 mM TEGDMA significant changes were
ound after 15 min  of incubation, 3.7% decrease of [GSH] was
etected (Fig. 5). According to Lefeuvre et al. incubation gin-
ival fibroblasts with low concentration of TEGDMA (0.3 mM)
enerated a high rate of GSH disappearance, at 30 min  GSH
evel decreased by more  than 50%. Comparison of in vitro and
ellular experiments suggest that the decrease of GSH level
s not a consequence of direct interaction with TEGDMA. In
efeuvre’s paper the possible role of glutathione-S-transferase
as put forward. The results of the present paper suggest
n additional target – mitochondria – for TEGDMA’s action.
he suggested mechanisms for TEGMA’s cytotoxicity do not
xclude each other.
.3.2.  H2O2 production  with  FADH2-linked  substrates
Succ  and  ˛-GP)  and  the  effect  of  inhibiting  the  reverse
lectron  transport
rom FADH2 linked respiratory substrates most of the elec-
rons are transported to oxygen as the final electron acceptor
ia the Complexes III and IV. It is well documented however,
hat with succinate in the absence of ADP a high  m is gen-
rated that drives a certain flux of electrons from coenzyme
 (CoQ) to flow towards the CI, in a direction that is inverse
o normal. This phenomenon is referred to as the reverse
lectron transport (RET) mechanism [82,83] that results in the
onversion of NAD+ to NADH at the CI. RET is the predominant
OS-generator when no ADP is present and the mitochondria
re supported by either succinate or -GP [40,53]. TEGDMA
owered the rate of the mitochondrial H2O2 production by 42%
for Succ) or 47% (for -GP) (Fig. 3C,D). This seemingly paradox-
cal phenomenon can be attributed to a contribution by the
o-called reverse electron transport (RET) mechanism, a back-
ard flow of electrons from the reduced CoQH2 towards the
I (and NAD+) [50,84–88]. CAT hyperpolarized m and there-
ore restored the RET in the DMSO-treated control group. In
he TEGDMA-treated mitochondria, however, H2O2 production
as less efficient due to inhibition of the CI (Fig. 3C,D).
.4.  Relationship  between  inhibition  of  Complex  I  and
he NAD(P)H  level  in  TEGDMA-treated  mitochondria
omplex I substrates (-KG, GM)  led to NADH formation
Fig. 6A,B), because these substrates are metabolized by the
ehydrogenases to yield NADH. In the presence of ADP most
f the NADH became oxidized, however, addition of TEGDMA
ncreased the steady state level of NADH/NAD (Fig. 6A,B).
his observation is crucial since it implies that TEGDMA does
nhibit the CI, but does not compromise the related dehy-
rogenases. With non-Complex I substrates (e.g. Succ, -GP)
he formation of NADH can unambiguously be attributed
o RET as the respective dehydrogenases do not produce
ADH. Addition of ADP to energized mitochondria decreased
he steady state level of NADH for all the tested respi-
atory substrates (Fig. 6A–D), because (i.) ADP stimulates
he respiration, (ii.) a higher rate of the electron flow pro-
otes NADH oxidation, and (iii.) an ADP-induced decrease
n the membrane potential abolishes the reverse electron 0 1 8 ) e166–e181 e177
flow [89]. TEGDMA induced different responses in mitochon-
dria depending on the substrate used for energization. With
CI substrates TEGDMA-mediated inhibition of the Complex
I withheld electrons from reaching the distal sequences of
respiratory chain; consequently, NAD+ mostly got reduced to
NADH (Fig. 6A,B). In the presence of succinate or -GP the
addition of TEGDMA preceded the administration of ADP to
mitochondria (Fig. 6C,D). In succinate-supported mitochon-
dria addition of ADP was unable to drop NADH concentration
to the control level, because CI was inhibited, thus the accu-
mulated NADH was unable to be oxidized (Fig. 6C). For more
detailed explanation see also Ref. [44].
4.5.  ATP  production  in  TEGDMA-challenged
mitochondria
In order to minimize the contribution of the adenylate kinases
(AKs) to the mitochondrial ATP generation the AK inhibitor 2-
amino-phoshponophentanoate (AP5) [90] was applied in the
experiments that assessed ATP production. In the presence of
ADP and the absence of any respiratory substrates only the AK-
related ATP synthesis could be detected; the AK activity was
only partially inhibited. Addition of the respiratory substrate
(GM or Succ) led to the initiation of OXPHOS. In GM-supported
mitochondria TEGDMA lowered the rate of ATP synthesis by
86% (Fig. 7). This observation suggests that TEGDMA, which
was inhibiting the CI, caused depolarization and the remain-
ing proton gradient was not sufficient to support a high rate of
OXPHOS; compromised ATP synthesis leads to cellular bioen-
ergetic insufficiency and eventually necrotic cell death.
4.6.  Complex  I  activity  in  TEGDMA-treated
mitochondria
The direct measurement of CI activity proved that TEGDMA
can indeed inhibit the CI. The immediate effect of TEGDMA
suggests that CI can in fact be a primary target of this resin
monomer. In rotenone-treated (CI inhibitor) cells oxidative
stress, glutathione depletion, and DNA damage were detected
with a subsequently increased prevalence of apoptosis [80].
It has been described that various inhibitors of the CI are
able to stimulate the mitochondrial ROS production and cause
MAPK/NF-B activation [91]. Furthermore, the extent of CI
inhibition can determine the type of cell death induced. Low
doses of CI inhibitors generally induce apoptosis, while higher
doses of the same compound may evoke necrotic cell death
[37].
Our study focused on the acute effects of TEGDMA and
the results do not contradict the observations made by Yeh
et al. [31]. The development of TEGDMA-induced changes
which were attributed to NOX4 activation required hours and
changes in the gene expression of NOX4 were observed [31].
Recently, it was reported that inhibition of the CI by rotenone
can stimulate NOX2 expression [92]. Thus, we propose that the
CI is an immediate target of TEGDMA and that the activation
of various signal transduction mechanisms may be required
to activate the NOX isoenzymes.
The effects and consequences of inhibitory action of
TEGDMA on respiratory Complex I are summarized on Fig. 8.
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Fig. 8 – Schematic summary of TEGDMA-induced mitochondrial damage. The primary target of TEGDMA is identified as the
CI. The effects of CI inhibition are decreased O2 consumption, stimulation of H2O2 production, impairment of mitochondrial
H2O2 elimination with a consequent oxidative stress, and apoptosis. The decrease of ATP synthesis at high TEGDMA
concentrations can create necrotic type of cell death. For simplicity the reverse electron flow (see Section 4.3.2) is not
indicated on the figure. Abbreviations: IM:  inner mitochondrial membrane; IMS: intermembrane space; OM:  outer
ond
r
membrane; CI, II, III, IV: respiratory complexes,  m: mitoch
5.  Conclusions
We  identified the CI of the mitochondrial electron transport
chain as a target of TEGDMA resin monomer. Addition of
TEGDMA results in inhibition of the CI-dependent oxygen con-
sumption, depolarization of mitochondrial membrane, and
consequently decrease in ATP production via OXPHOS, there-
fore TEGDMA causes bioenergetic insufficiency. Inhibition of
CI by TEGDMA enhances the mitochondrial H2O2 (ROS) for-
mation and impairs ROS elimination. The direct interaction
between TEGDMA and reduced glutathione is unlikely to be a
major component in the toxicity.
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